SUSCEPTIBILITY OF MYCOPLASMA-PNEUMONIAE TO SEVERAL NEW QUINOLONES, TETRACYCLINE, AND ERYTHROMYCIN

被引:41
作者
KENNY, GE
CARTWRIGHT, FD
机构
[1] Department of Pathobiology, Univ. of Washington School of, Public Health/Community Med., Seattle
关键词
D O I
10.1128/AAC.35.3.587
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mycoplasma pneumoniae (39 strains) was most susceptible to two quinolones, WIN 57273 and sparfloxacin, with MICs for 90% of the strains (MIC90s) of 0.125 and 0.25-mu-g/ml, respectively. It was susceptible to ofloxacin and ciprofloxacin at 2-mu-g/ml and to lomefloxacin and fleroxacin at 4-mu-g/ml. The MIC90 of erythromycin was 0.062-mu-g/ml, and that of tetracycline was 1-mu-g/ml.
引用
收藏
页码:587 / 589
页数:3
相关论文
共 26 条
[1]  
FELMINGHAM D, 1989, DRUG EXP CLIN RES, V15, P59
[2]   LONG-TERM EPIDEMIOLOGY OF INFECTIONS WITH MYCOPLASMA-PNEUMONIAE [J].
FOY, HM ;
KENNY, GE ;
COONEY, MK ;
ALLAN, ID .
JOURNAL OF INFECTIOUS DISEASES, 1979, 139 (06) :681-687
[3]   ACTIVITY OF MACROLIDES AGAINST ORGANISMS RESPONSIBLE FOR RESPIRATORY-INFECTION WITH EMPHASIS ON MYCOPLASMA AND LEGIONELLA [J].
HARA, K ;
SUYAMA, N ;
YAMAGUCHI, K ;
KOHNO, S ;
SAITO, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1987, 20 :75-80
[4]   SUSCEPTIBILITY OF MYCOPLASMA PNEUMONIAE TO 21 ANTIBIOTICS IN VITRO [J].
JAO, RL ;
FINLAND, M .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1967, 253 (06) :639-+
[5]   WIN-57273, A NEW FLUOROQUINOLONE WITH ENHANCED INVITRO ACTIVITY VERSUS GRAM-POSITIVE PATHOGENS [J].
KAATZ, GW ;
SEO, SM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (07) :1376-1380
[7]  
KENNY GE, 1965, J IMMUNOL, V95, P19
[8]   SUSCEPTIBILITIES OF GENITAL MYCOPLASMAS TO THE NEWER QUINOLONES AS DETERMINED BY THE AGAR DILUTION METHOD [J].
KENNY, GE ;
HOOTON, TM ;
ROBERTS, MC ;
CARTWRIGHT, FD ;
HOYT, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (01) :103-107
[9]  
KENNY GE, 1985, MANUAL CLIN MICROBIO, P407
[10]   HUMAN RESPIRATORY-TRACT INFECTIONS WITH MYCOPLASMAS AND THEIR INVITRO SUSCEPTIBILITY TO TETRACYCLINES AND SOME OTHER ANTIBIOTICS [J].
MARDH, PA .
CHEMOTHERAPY, 1975, 21 :47-57